Your browser doesn't support javascript.
loading
miR-497-5p-RSPO2 axis inhibits cell growth and metastasis in glioblastoma.
Chen, Kun; Wang, Zheng; Zong, Qi-Bei; Zhou, Meng-Ying; Chen, Qing-Fa.
Afiliação
  • Chen K; School of Medicine, Liaocheng University, Shandong, 252000, China.
  • Wang Z; Institute for Tissue Engineering and Regenerative Medicine, Liaocheng University/Liaocheng People's Hospital, Shandong, 252000, China.
  • Zong QB; Department of Gastroenterology, The Second People's Hospital of Nanyang, Henan, 473000, China.
  • Zhou MY; Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Hubei, 430081, China.
  • Chen QF; Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Hubei, 430081, China.
J Cancer ; 13(4): 1241-1251, 2022.
Article em En | MEDLINE | ID: mdl-35281864
ABSTRACT
Numerous studies have found a relationship between cancer formation and aberrant microRNA expression, however the biological significance of miR-497-5p in glioblastoma (GBM) is still unknown. Compared to normal brain glial cells, miR-497-5p expression in GBM tissues was substantially lower in our study. The microRNA miR-497-5p targets R-spondin 2 (RSPO2) only when it is present. RSPO2 silencing has the same effect on GBM cells as miR-497-5p silencing, as demonstrated before. Additional mechanistic investigations have shown that miR-497-5p suppresses the Wnt/ß-catenin signaling pathway by targeting RSPO2 to reduce cell proliferation, migration, and invasion. A negative correlation was discovered between MiR-497-5p and RSPO2 in 37 of the GBM tumors studied. MiR-497-5p-RSPO2 axis controls Wnt/ß-catenin signaling and plays a function in GBM carcinogenesis, suggesting that it may be a therapeutic target to reduce GBM growth, as shown by our research findings.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China